Categories: News

Amedisys Announces Third Quarter Earnings Release and Conference Call Date

BATON ROUGE, La., Oct. 13, 2021 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, will report results for the third quarter ended September 30, 2021, after the market closes on November 2, 2021. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on November 3, 2021.

To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (toll-free) or (412) 902-1028 (toll). A replay of the call will be available through December 3, 2021, by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and entering access ID 13724253.

A live webcast of the call will be accessible through the Company website on the Investor Relations section at http://investors.amedisys.com.

About Amedisys:

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and higher acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,900 hospitals and 78,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With ~21,000 employees, in 527 care centers in 38 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 418,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.

Contact:
Nick Muscato Kendra Kimmons
Amedisys, Inc. Amedisys, Inc.
Investor Relations Media Relations
615.928.5452 225.299.3720
IR@amedisys.com Kendra.kimmons@amedisys.com

Staff

Recent Posts

Functional Brands Inc. to Participate at the Sidoti Year End Virtual Investor Conference

Lake Oswego, Oregon--(Newsfile Corp. - December 8, 2025) - Functional Brands Inc. (NASDAQ: MEHA), a…

3 minutes ago

Cheelcare Has a Record Month of Sales and Celebrates Milestone of 2,000 Companions Sold

Markham, Ontario--(Newsfile Corp. - December 8, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in…

1 hour ago

SJTU International Gen Z Students Explore Shanghai’s Innovation Ecosystem

SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- Shanghai Jiao Tong University's Antai Global Summer Program (AGSP)…

2 hours ago

Evotec Closes Sale of Just – Evotec Biologics’ Toulouse Site to Sandoz

All closing requirements satisfied following announcement of a non-binding term-sheet agreement in July and signing…

5 hours ago

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

8 hours ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

8 hours ago